UNSPSC 51442406: Iobenguane

This classification denotes an iodinated contrast dye with the molecular formula C8H10IN3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 35MRW7B4AD, chemically known as guanidine, ((3-iodophenyl)methyl)- but more generally known as iobenguane, which bears U.S. National Institutes of Health Compound Identifier 60860. The European Medicines Agency schedules Iobenguane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32630.

IOBENGUANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: IC1CC(C/N=C(/N)N)CCC1. SMILES: IC1CC(C/N=C(/N)N)CCC1. Most nations schedule Iobenguane under HS 28444030.

UNSPSC 51442406 Iobenguane is a Commodity code, but the recent state and local opportunities tagged under it show minimal alignment with the code's nominal scope. The opportunities posted since June 2026 cover radiologic and X-ray equipment procurement, extended warranty services for imaging systems, maintenance service availability for specialized inspection systems, and copper sulfate chemical supply—none of which map to iobenguane, a radiopharmaceutical used in nuclear medicine imaging. The mismatch suggests either systematic miscoding in the jurisdictions' procurement systems or an administrative error in the tagging. State and local agencies soliciting under this code appear to be using it as a catch-all for capital equipment and support services unrelated to pharmaceutical procurement.

The limited recent activity spans three states: Arizona (Maricopa County community college radiologic equipment and installation, IFB362910, due October 22, 2026), Florida (Escambia County Correction extended warranty for X-ray equipment, due August 19, 2026; Broward County Aviation Department RFI for Rapiscan system maintenance services, due July 28, 2026; and Pasco County as-needed copper sulfate supply, due June 26, 2026). The issuing bodies include county government departments and special-purpose entities. Given the absence of iobenguane-specific opportunities and the clear mismatch between the code's pharmaceutical definition and the actual goods and services being solicited, this code shows little relevant procurement activity for vendors in the radiopharmaceutical or nuclear medicine imaging space.